Showcase Your Research at the Poster Session | Wednesday, January 28 |
Join us for the Poster Session during the afternoon break in the exhibition hall. This session is free for all attendees and offers a fantastic opportunity to showcase and discuss the latest scientific research.
To participate, please complete the SUBMISSION FORM by Monday, January 12 latest. Further instructions will be provided upon approval.
With an audience of 80+ RNAi pioneers from top biotechs, large pharma, and leading academic institutions, this is your prime opportunity to display your latest advancements and forge the connections that drive progress.
Don't miss this chance to present your work and:
- Demonstrate thought leadership in extrahepatic delivery, novel chemistries, AI-driven target discovery, or CMC strategies for complex oligonucleotides.
- Gain unparalleled visibility for your research, platform technology, or pipeline assets among a concentrated audience of key decision-makers.
- Engage in meaningful discussions to receive direct feedback and insights from senior scientists, CSOs, and potential collaborators.
- Attract the attention of investors and industry stakeholders scouting for the next licensing, partnership, or co-development opportunity.
How to Submit Your Poster
- You must first register your place to attend the 7th RNAi-Based Therapeutics Summit
- Submit an abstract for review to showcase your poster during the Scientific Poster Session
- You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
Please note, there is no additional charge, but you must be attending the conference to submit an abstract. Posters should not be used for sales and marketing purposes. All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions.
Explore the Full Event Guide
- 25+ expert speakers from pioneering biotechs and large pharma, including Sanegene Bio, AbbVie, Judo Bio, and more, sharing exclusive data and case studies.
- Actionable insights to conquer extrahepatic delivery for CNS, muscle, and cardiac tissues with novel strategies like aptamers, bispecifics, and exosomes.
- Dedicated deep-dives on the hottest applications: from obesity and metabolic disease to neurology, oncology, and more.
- Critical regulatory and CMC strategies to overcome complex synthesis, scale-up, and IND-enabling hurdles for late-stage clinical success.
